ConductScience.org, home

Paper41454181

Neuroimmune Dysregulation and AI-Driven Therapeutic Strategies in Alzheimer's Disease.

Ghosh S and 6 others. Cell Mol Neurobiol, 2025. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Neuroimmune Dysregulation and AI-Driven Therapeutic Strategies in Alzheimer's Disease. Papers, record 41454181. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41454181

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Neuroimmune Dysregulation and AI-Driven Therapeutic Strategies in Alzheimer's Disease.
PubMed
Journal
Cell Mol Neurobiol
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
2
iCite
Revised in PubMed
2026-06-26
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Alzheimer DiseaseMajor topic
Artificial IntelligenceMajor topic
NeuroimmunomodulationMajor topic
Humans
Animals
Microglia

References161

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123768694Propranolol reduces cognitive deficits, amyloid and tau pathology in Alzheimer's transgenic mice.Int J Neuropsychopharmacol2013https://conductscience.org/library/papers/23768694PubMed
233423792Blood-Brain Barrier Dynamics to Maintain Brain Homeostasis.Trends Neurosci2021https://conductscience.org/library/papers/33423792PubMed
338042110TREM2 regulates microglial lipid droplet formation and represses post-ischemic brain injury.Biomed Pharmacother2024https://conductscience.org/library/papers/38042110PubMed
425100587Neuronal hyperactivity recruits microglial processes via neuronal NMDA receptors and microglial P2Y12 receptors after status epilepticus.J Neurosci2014https://conductscience.org/library/papers/25100587PubMed
528003153Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-β and cognitive function in APP/PS1 mice.Brain Behav Immun2017https://conductscience.org/library/papers/28003153PubMed
631736980OLT1177 (Dapansutrile), a Selective NLRP3 Inflammasome Inhibitor, Ameliorates Experimental Autoimmune Encephalomyelitis Pathogenesis.Front Immunol2019https://conductscience.org/library/papers/31736980PubMed
738040385MCC950 reduces autophagy and improves cognitive function by inhibiting NLRP3-dependent neuroinflammation in a rat model of Alzheimer's disease.Brain Behav Immun2024https://conductscience.org/library/papers/38040385PubMed
836335715Reprogramming cell fates towards novel cancer immunotherapies.Curr Opin Pharmacol2022https://conductscience.org/library/papers/36335715PubMed
940122810Enhancing TREM2 expression activates microglia and modestly mitigates tau pathology and neurodegeneration.J Neuroinflammation2025https://conductscience.org/library/papers/40122810PubMed
1028602351A Unique Microglia Type Associated with Restricting Development of Alzheimer's Disease.Cell2017https://conductscience.org/library/papers/28602351PubMed
1122766509Lipid metabolism and neuroinflammation in Alzheimer's disease: a role for liver X receptors.Endocr Rev2012https://conductscience.org/library/papers/22766509PubMed
1239240134Exploring neuroglial signaling: diversity of molecules implicated in microglia-to-astrocyte neuroimmune communication.Rev Neurosci2025https://conductscience.org/library/papers/39240134PubMed
1335756927PD-1/PD-L Axis in Neuroinflammation: New Insights.Front Neurol2022https://conductscience.org/library/papers/35756927PubMed
1438785566Spatial Multi-Omics in Alzheimer's Disease: A Multi-Dimensional Approach to Understanding Pathology and Progression.Curr Issues Mol Biol2024https://conductscience.org/library/papers/38785566PubMed
1527547730PCA as a practical indicator of OPLS-DA model reliability.Curr Metabolomics2016https://conductscience.org/library/papers/27547730PubMed
1630587772The Role of APOE and TREM2 in Alzheimer's Disease-Current Understanding and Perspectives.Int J Mol Sci2018https://conductscience.org/library/papers/30587772PubMed
1740122396Fluid-based biomarkers for neurodegenerative diseases.Ageing Res Rev2025https://conductscience.org/library/papers/40122396PubMed
1838077952CD8+ T cells in brain injury and neurodegeneration.Front Cell Neurosci2023https://conductscience.org/library/papers/38077952PubMed
1934057026On the reactive states of astrocytes in prion diseases.Prion2021https://conductscience.org/library/papers/34057026PubMed
2032973758Affective Immunology: The Crosstalk Between Microglia and Astrocytes Plays Key Role?Front Immunol2020https://conductscience.org/library/papers/32973758PubMed

See all 161 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
42975757Exosomes in regenerative medicine from biological messengers to engineered nanocarriers for precision therapeutics.Discov Nano2026https://conductscience.org/library/papers/42975757PubMed
42206050AI-driven insights into protein misfolding and innate immunity in neurodegenerative diseases.Front Immunol2026https://conductscience.org/library/papers/42206050PubMed
41977473Microglia-Astrocyte Cooperation and Peripheral T Cells in Alzheimer's Disease: State-of-the-Art and Treatment Perspectives.Int J Mol Sci2026https://conductscience.org/library/papers/41977473PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41454181

GET https://conductscience.org/api/papers/v1/41454181/references?page=2